Editorial · 31 May 2025
Research articlePublished 31 Aug 2016
Concordant Versus Discordant Ultrasound Guided Breast Biopsy Results: How They Effect Patient Management?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: To determine concordant or discordant breast biopsy results and see their effect on patient management and outcome. Material and methods: This descriptive analytical study was conducted at the department of Diagnostic Radiology Aga Khan University Hospital Karachi Pakistan from January to December 2013. All patients fulfilling our selection criteria were included. A concordant result was defined when the imaging and pathology results concluded same diagnosis and a discordant result when they did not match. All histopathology results were reviewed and a decision was made regarding concordant/discordant biopsy results and recommendations given for further management of all patients. Results: A total of 282 patients underwent core biopsy of lesions in the breast. The mean age was 47.87 ± 13.99 years. Out of 282 lesions biopsied, 172 were concordant malignant and 105 were concordant benign. Two lesion out of 282 were borderline or high risk, one case was discordant benign and 2 cases discordant malignant. The appropriate management for all cases was recommended after radiology-pathology correlation. Conclusion: Cautious Radiology-Pathology co relation is indispensable in addition to appropriate post biopsy management for managing a successful core breast biopsy program. This practice identifies a substantial number of false negative results of core biopsy by identifying discordant results avoiding delays in diagnosis of breast cancer.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Medical Oncology and Therapeutics.
Opinion · 31 May 2025
The Importance of Early-Phase Clinical Trials in Developing New Cancer Therapies
Short communication · 31 May 2025
Understanding Cancer Drug Resistance: Mechanisms and Solutions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Oncology and Therapeutics
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Imrana Masroor”
- BylineArticles whose byline prints “Saira Naz Sufian”
- BylineArticles whose byline prints “Shaista Afzal”
- BylineArticles whose byline prints “Saba Sohail”
- BylineArticles whose byline prints “Hafsa Qayyum”
